ArticleEpidemics2011
Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity.
Article in Epidemics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 35 citations in OpenAlex.
- Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand.Human vaccines & immunotherapeutics · 2024Article
- Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella-Zoster Diagnosis.Pathogens (Basel, Switzerland) · 2022Article
- Varicella in Tshuapa Province, Democratic Republic of Congo, 2009-2014.Tropical medicine & international health : TM & IH · 2019Article
- Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.The Pediatric infectious disease journal · 2018Article
- Has VZV epidemiology changed in Italy? Results of a seroprevalence study.Human vaccines & immunotherapeutics · 2017Article
- Seroprevalence and Risk Factors of Varicella Zoster Infection in Iranian Adolescents: A Multilevel Analysis; The CASPIAN-III Study.PloS one · 2016Article
- Rates of vaccine evolution show strong effects of latency: implications for varicella zoster virus epidemiology.Molecular biology and evolution · 2015Article
- Evolution of cocirculating varicella-zoster virus genotypes during a chickenpox outbreak in Guinea-Bissau.Journal of virology · 2014Article
- Risk factors for susceptibility to varicella in newly arrived adult migrants in Canada.Epidemiology and infection · 2014Article
- High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa.PloS one · 2014Article
- Use of oral fluid to examine the molecular epidemiology of varicella zoster virus in the United Kingdom and continental Europe.The Journal of infectious diseases · 2013Article
- Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study.PloS one · 2013Article
- Effective degree household network disease model.Journal of mathematical biology · 2013Article
- Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.BMC infectious diseases · 2012Article
- Varicella Pneumonia: Case Report and Review of a Potentially Lethal Complication of a Common Disease.Journal of investigative medicine high impact case reportsArticle
- Maritime varicella illness and death reporting, U.S., 2010-2015.Travel medicine and infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
The epidemiology and severity of infections can vary dramatically in different geographical regions. Varicella zoster virus (VZV) is a particularly tractable model for investigating such global differences, since infections can be unambiguously identified. VZV is spread by aerosol to cause chickenpox, which, in temperate countries, is a relatively benign childhood infection; yet in tropical countries it tends to occur at later age, a trend associated with markedly increased severity including complications, hospitalization, and overall burden of care. To investigate global differences in the epidemiology of chickenpox we studied a population in Guinea Bissau, which in contrast to other tropical countries has an unexpectedly early age of infection with VZV, comparable to temperate latitudes. In this study we used detailed records from over 3000 houses during an outbreak of chickenpox, combined with viral genetic information on routes of infection, to obtain precise estimates of disease transmission within and between houses. This community contains many large households in which different families live under a single roof, in living quarters divided by partitions. Our data show that household infectivity in tropical Guinea Bissau is reduced four-fold compared with temperate climates (14.8% versus 61-85%), with an intermediate rate between members of the same family who are in more intimate contact (23.5%). All else being equal, these lower infection rates would be expected to lead to a later age of infection as is commonly seen in other tropical countries. The young age of infection, which had drawn our attention to the Guinea Bissau population, can however be explained by the exceptionally large household sizes (mean 14.5 people). We have combined genetic and demographic data to show that the epidemiology of chickenpox in tropical Guinea Bissau is dependent on the interaction of the social and physical environments. The distinctive clinical presentation of VZV and its ubiquitous distribution make it an attractive model for estimating the variables that contribute to global differences in the transmission of airborne viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.